About Company:
Avan Bahman Chemical Company, established in February 2021 with the aim of promoting public health through the production of essential pharmaceutical ingredients required by domestic pharmaceutical companies, has begun its activities relying on the knowledge and expertise of domestic specialists. The company adopts an innovative approach and adheres to international standards, focusing on the production of active pharmaceutical ingredients for anti-cancer, cardiovascular, diabetes, central nervous system, and orphan drugs.
One of the distinguishing objectives of this company in the pharmaceutical ingredient production industry is to engage in the early stages of production. This not only ensures self-sufficiency in producing these products but also contributes to reducing currency dependency for the country.
Avan Bahman Chemical is a knowledge-based company within the Cobel Group, which, by employing top experts and emphasizing research and development of novel molecules, has taken the initial steps towards creating knowledge for the production of desired molecules. At the same time, the plan to establish an industrial-scale production site in accordance with current world standards is underway with the assistance of domestic experts and the utilization of knowledge and experience from international consultants.
Avan Chemical considers its experienced and capable human resources as its main asset. By relying on professional and competent teams, the company prioritizes the production of high-quality raw materials for the country's required medications while emphasizing the safety of employees and the preservation of environmental health.
